Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hip Fractures
Biocoral announces positive results of trial for treatment of hip fractures
February 14th, 2007
Biocoral, Inc., (BCRA) announced that it has received on January 5, 2007, the final report of its prospective randomized clinical multicenter trial for treatment of hip fractures associated with bone demineralization/or low bone mass. Osteoporosis and its bone complications including hip fractures have been, are and will be in the future a public health problem for the major economies for the world. Because of the increased life expectancy of the population, each family had, has or will have a grandparent or close relative, fall victim to what the public health authorities do not hesitate to call as a plague. The company French subsidiary has been...
Source: Medical Patent Law Weekly (2007-02-14)
|
